AMYLIN PHARMACEUTICALS INC Selling, General and Administrative Expense
AMYLIN PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $108.54 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-06-30 was $108.54M, a 66.43% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-03-31 was $110.35M, a 70.75% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2011-12-31 was $78.32M, a 25.22% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2011-09-30 was $63.06M, a 9.94% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $271.22M, a 2.04% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $276.88M, a 16.22% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2009 was $330.49M, a 16.36% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2008 was $395.11M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2012-06-30 | $108.54M 10-Q · filed 2012-08-03 | $218.89M 10-Q · filed 2012-08-03 | $297.21M derived: sum of 3 quarters · filed 2012-08-03 | $360.27M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2012-03-31 | $110.35M 10-Q · filed 2012-05-07 | $188.67M derived: sum of 2 quarters · filed 2012-05-07 | $251.73M derived: sum of 3 quarters · filed 2012-05-07 | $316.95M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-12-31 | $78.32M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $141.38M derived: sum of 2 quarters · filed 2012-02-22 | $206.60M derived: sum of 3 quarters · filed 2012-08-03 | $271.22M 10-K · filed 2012-02-22 | ||||
| 2011-09-30 | $63.06M 10-Q · filed 2011-10-28 | $128.28M derived: sum of 2 quarters · filed 2012-08-03 | $192.90M 10-Q · filed 2011-10-28 | $255.45M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-06-30 | $65.22M 10-Q · filed 2012-08-03 | $129.84M 10-Q · filed 2012-08-03 | $192.39M derived: sum of 3 quarters · filed 2012-08-03 | $262.41M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-03-31 | $64.63M 10-Q · filed 2012-05-07 | $127.17M derived: sum of 2 quarters · filed 2012-05-07 | $197.19M derived: sum of 3 quarters · filed 2012-05-07 | $268.19M derived: sum of 4 quarters · filed 2012-05-07 | ||||
| 2010-12-31 | $62.55M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $132.57M derived: sum of 2 quarters · filed 2012-02-22 | $203.57M derived: sum of 3 quarters · filed 2012-02-22 | $276.88M 10-K · filed 2012-02-22 | $288.65M 10-K · filed 2011-02-25 | |||
| 2010-09-30 | $70.02M 10-Q · filed 2011-10-28 | $72.73M 10-Q · filed 2010-11-08 | $141.02M derived: sum of 2 quarters · filed 2011-10-28 | $214.33M 10-Q · filed 2011-10-28 | $223.64M 10-Q · filed 2010-11-08 | $285.12M derived: sum of 4 quarters · filed 2012-02-22 | ||
| 2010-06-30 | $71.00M 10-Q · filed 2011-08-08 | $74.16M 10-Q · filed 2010-08-05 | $144.31M 10-Q · filed 2011-08-08 | $150.91M 10-Q · filed 2010-08-05 | $215.10M derived: sum of 3 quarters · filed 2012-02-22 | $295.19M derived: sum of 4 quarters · filed 2012-02-22 | ||
| 2010-03-31 | $73.31M 10-Q · filed 2011-05-05 | $144.10M derived: sum of 2 quarters · filed 2012-02-22 | $224.19M derived: sum of 3 quarters · filed 2012-02-22 | $316.24M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $70.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $150.88M derived: sum of 2 quarters · filed 2012-02-22 | $242.93M derived: sum of 3 quarters · filed 2012-02-22 | $330.49M 10-K · filed 2012-02-22 | $343.86M 10-K · filed 2011-02-25 | |||
| 2009-09-30 | $80.09M 10-Q · filed 2010-11-08 | $172.14M derived: sum of 2 quarters · filed 2010-11-08 | $259.70M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $92.05M 10-Q · filed 2010-08-05 | $179.61M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $395.11M 10-K · filed 2011-02-25 |